A bombshell new study from Brown University has found that the spike protein from COVID-19 turns benign cancer cells into 'indestructible tumors'.
According to the team of scientists, led by Dr. Wafik El-Deiry, the director of Brown's Legorreta Cancer Center, spike protein helps cancer cells grow and survive and resist chemotherapy.
Naturalnews.com reports: El-Deiry and his colleagues observed that when cancer cells encountered spike protein subunits, it reduced the activity of p53, a protein that helps defend the body against tumors.
The study also used chemotherapy drugs to activate the p53 genes, but instead of dying, the researchers found that cancer cells containing spike protein subunits displayed increased resistance to chemotherapy, a standard treatment for various types of cancers.
The study examined age-adjusted mortality rates for 20 different types of cancer in Japan using official statistics on death, SARS-CoV-2 infections and vaccination rates from 2020 to 2022.
The data shows some excess cancer mortalities of 1.1 percent after the mass vaccination campaigns with the first and second doses in 2021, and then higher excess cancer mortalities of 2.1 percent in 2022 after the rollout of the third vaccine dose.
The researchers argued that even with reduced cancer screenings and limited healthcare access at that time, the mortality rate increase in these cancer types is still unexplainable due to resolved restrictions on healthcare access for cancer screenings and treatments in 2022.
No comments:
Post a Comment